[صفحه اصلی ]   [Archive]  
:: صفحه اصلي :: درباره نشريه :: آخرين شماره :: تمام شماره‌ها :: جستجو :: ثبت نام :: ارسال مقاله :: تماس با ما ::
:: دوره 8، شماره 4 - ( 4-1396 ) ::
جلد 8 شماره 4 صفحات 228-238 برگشت به فهرست نسخه ها
Promising role for Gc-MAF in cancer immunotherapy: from bench to bedside
چکیده:   (351 مشاهده)

Immunotherapy has been used for years in many types of cancer therapy. Recently, cancer immunotherapy has focused on mechanisms which can enhance the development of cell-mediated immunity. Anticancer medications are administered to inhibit immunosuppressive factors such as nagalase enzyme, which is produced by neoplastic cells and destroys macrophage activating factor (Gc-MAF). Anti-neoplastics medications can also enhance immune-cell activity against tumors. Such medications show great potential in cancer immunotherapy using natural human mechanisms against neoplasms.

متن کامل [PDF 548 kb]   (19 دریافت)    
نوع مطالعه: Review Article | موضوع مقاله: Oncology
دریافت: ۱۳۹۵/۶/۱ | پذیرش: ۱۳۹۵/۱۲/۱۶ | انتشار: ۱۳۹۶/۵/۷
ارسال نظر درباره این مقاله
نام کاربری یا پست الکترونیک شما:

کد امنیتی را در کادر بنویسید >



DOI: 10.22088/cjim.8.4.228


XML   English Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Saburi E, Saburi A, Ghanei M. Promising role for Gc-MAF in cancer immunotherapy: from bench to bedside . Caspian J Intern Med. 2017; 8 (4) :228-238
URL: http://caspjim.com/article-1-847-fa.html
Promising role for Gc-MAF in cancer immunotherapy: from bench to bedside . 1. 1396; 8 (4) :228-238

URL: http://caspjim.com/article-1-847-fa.html

دوره 8، شماره 4 - ( 4-1396 ) برگشت به فهرست نسخه ها
Caspian Journal of Internal Medicine
Persian site map - English site map - Created in 0.048 seconds with 792 queries by yektaweb 3461